Revenio Group Corporation: Revenio Group Corporation publishes Annual Report 2014

Revenio Group Corporation     Stock Exchange Release February 26, 2015 at 09:00

REVENIO GROUP CORPORATION PUBLISHES ANNUAL REPORT 2014

Today, Revenio Group Corporation published the annual report for 2014. The AR,
available in Finnish in PDF format on the corporations' website at
www.reveniogroup.fi, contains financial statements for the corporation and
parent company, the report of the Board of Directors, auditors report and a
report on corporate governance.

The AR will be published in print in week 12. To order a copy, place an order
with Revenio Group Corporation, Äyritie 22, FI-01510 Vantaa, tel.
+358 50 382 0131 (on weekdays between 9.00-16.00) or by e-mail
elina.kari@revenio.fi.


Revenio Group Corporation
Olli-Pekka Salovaara
President and CEO

For further information, please contact:
Olli-Pekka Salovaara, President and CEO, mobile +358 40 567 5520
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Key media
www.revenio.fi


The Revenio Group in brief

Revenio is a Finnish health tech group whose core business lies in tonometers.
The Revenio Health Tech segment comprises the business operations of Icare
Finland Oy and Oscare Medical Oy, which specializes in osteoporosis screening
and assessment. In addition, Revenio has identified new growth opportunities
relating to health tech in which common denominators are screening, follow-up
and the global need to make cost savings in health care through preventive
measures. Revenio seeks vigorous growth in health technology, both organically
and through acquisitions and mergers.

In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating
margin for continuing operations standing at 27,5%. The Revenio Group
Corporation is listed on Nasdaq Helsinki.


[HUG#1897160]